The lawsuits involve different medications, but they were centralized into the MDL because they share common questions of fact: Each lawsuit contains substantially similar allegations about GLP-1 RAs (specifically, Ozempic, Wegovy, Rybelsus, Trulicity, and/or Mounjaro) and their alleged propensity to cause gastrointestinal injuries. What Do Lawsuits Allege
Verifiable US address, though not clearly listed on the website: 480 Morris Ave, Summit, NJ 07901
February 11, 2026
GLP-1 secretion by microglial cells and decreased CNS expression in obesity
Therefore, while hormonal attenuation was observed in the WR group overall, we cannot conclude that patients with lower endogenous incretin levels derive greater benefit from GLP-1 receptor agonist therapy
The standard method uses bacteriostatic water, added slowly down the side of the vial so the powder dissolves without foaming